Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial
Sponsored by St. Luke's Hospital, Pennsylvania
About this trial
Last updated 3 years ago
Study ID
SLRI-2022-24
Status
Recruiting
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
Liposomal Bupivacaine (Exparel) has been recently studied as the active agent utilized in
various nerve block. Due to its liposomal form allowing for extended delivery, Exparel has
been used in various peri-operative nerve blocks among multiple orthopaedic specialties in
hopes of achieving improved pain control and decreased opioid use. This study compares the
efficacy and effect on opioid use of peripheral nerve blocks and local infiltration with and
without Exparel in patients undergoing foot and ankle surgery.
What are the participation requirements?
Inclusion Criteria
- Adult patients undergoing elective orthopaedic foot and ankle surgery at a single institution
- English speaking
- Able to provide consent to surgery and study participation
Exclusion Criteria
- Non-elective or emergent foot and ankle surgery
- Non-english speaking
- Does not possess medical decision making capacity
Locations
Location
Status
Recruiting